Evidence map›Paper›PMID 42216462›Full record

ArticleRevista de neurologia2026

Surgical Treatment of an Aneurysm in the Subacute Stage of Hemorrhagic Moyamoya Disease: Aneurysm Resection Combined With STA-MCA Bypass: A Case Report.

Yuezhu Cai, Jiancong Zheng, Jinghui Lin, Jie Wei, Pengyu Lin, Tao Feng, Jiaqi Lin, Haitao Xu

Abstract readCase Reports
In one paragraph

Article in Revista de neurologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuezhu CaiDepartment of Neurosurgery, Ningbo Key Laboratory of Neurological Diseases and Brain Function, The First Affiliated Hospital of Ningbo University, 315010 Ningbo, Zhejiang, China.
Jiancong ZhengDepartment of Neurosurgery, Ningbo Key Laboratory of Neurological Diseases and Brain Function, The First Affiliated Hospital of Ningbo University, 315010 Ningbo, Zhejiang, China.
Jinghui LinDepartment of Neurosurgery, Ningbo Key Laboratory of Neurological Diseases and Brain Function, The First Affiliated Hospital of Ningbo University, 315010 Ningbo, Zhejiang, China.
Jie WeiDepartment of Neurosurgery, Ningbo Key Laboratory of Neurological Diseases and Brain Function, The First Affiliated Hospital of Ningbo University, 315010 Ningbo, Zhejiang, China.
Pengyu LinDepartment of Neurosurgery, Ningbo Key Laboratory of Neurological Diseases and Brain Function, The First Affiliated Hospital of Ningbo University, 315010 Ningbo, Zhejiang, China.
Tao FengDepartment of Neurosurgery, Ningbo Key Laboratory of Neurological Diseases and Brain Function, The First Affiliated Hospital of Ningbo University, 315010 Ningbo, Zhejiang, China.
Jiaqi LinDepartment of Neurosurgery, Ningbo Key Laboratory of Neurological Diseases and Brain Function, The First Affiliated Hospital of Ningbo University, 315010 Ningbo, Zhejiang, China.
Haitao XuDepartment of Neurosurgery, Ningbo Key Laboratory of Neurological Diseases and Brain Function, The First Affiliated Hospital of Ningbo University, 315010 Ningbo, Zhejiang, China.

Funding

Key Research and Development Program of Zhejiang Province 2024C03281(SD2)
6 · The paper itself

Abstract

introductionThere is no consensus on the optimal management of intracranial aneurysms in patients with moyamoya disease. Here, we report a case of a patient in the subacute hemorrhagic stage of moyamoya disease with a presumed pseudoaneurysm detected on interval imaging, who was treated with aneurysm resection combined with superficial temporal artery (STA)-middle cerebral artery (MCA) bypass. This report illustrates a feasible individualized surgical approach for similar cases. CASE REPORT: A 27-year-old male without a prior history of cerebrovascular disease was admitted for a right temporal intracerebral hemorrhage following external ventricular drainage. Initial computed tomography angiography (CTA) at admission showed no aneurysm. One week later, follow-up CTA revealed a newly developed 10 × 9 mm aneurysm in the right MCA region. Subsequent digital subtraction angiography (DSA) demonstrated occlusion of the right MCA M1 segment with the development of characteristic moyamoya collateral networks. The patient underwent microsurgical resection of the aneurysmal lesion, combined with a right STA-MCA bypass. Postoperative imaging demonstrated complete obliteration of the aneurysm, patency of the bypass, and a reduction in moyamoya collateral vessels. Histopathological examination revealed a red blood cell clot surrounded by fibrous connective tissue without definitive evidence of a preserved arterial wall, consistent with a presumed pseudoaneurysm. The patient recovered well, with improved neurological function on follow-up imaging.

conclusionsIn patients with moyamoya disease, a peripheral aneurysmal lesion may become detectable on interval imaging after an initially negative CTA and may represent an unstable hemorrhage-related vascular lesion. In carefully selected cases, lesion resection combined with STA-MCA bypass during the subacute phase may be a feasible individualized treatment strategy, particularly when direct lesion treatment and hemodynamic revascularization are both required. However, longer clinical and imaging follow-up is needed before any firm conclusions can be drawn regarding outcome improvement, or prevention of rebleeding.

Indexed as

Cerebral HemorrhageCerebral RevascularizationIntracranial AneurysmMiddle Cerebral ArteryMoyamoya DiseaseTemporal ArteriesAdultAngiography, Digital SubtractionHumansMaleaneurysm resectionbypasscerebral hemorrhageintracranial aneurysmmoyamoya disease

Identifiers

PMID42216462
PMCPMC13221674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.